🇺🇸 VETERANS: A NEW BILL WANTS THE VA TO STUDY PEPTIDES 🇺🇸 Big news for our veteran community. Here's what's happening. 📅 WHAT HAPPENED On September 1, 2026, Rep. Nancy Mace (R-SC) introduced H.R. 10212, the PEPTIDES for Veterans Act. The full name is "Providing Evidence-based Peptide Therapies to Improve Delivery and Expanded Services for Veterans Act." ⚠️ WHERE IT STANDS TODAY • It has been referred to the House Committee on Veterans' Affairs • No cosponsors are listed yet • It has NOT passed either chamber • It is NOT law, and it is NOT a VA program This is a proposal. Nothing changes for veterans today. ━━━━━━━━━━━━━━━━━━━━ 🔍 WHAT THE BILL WOULD DO (3 STAGES) 1️⃣ REVIEW (180 days after enactment) The VA reviews federal peptide regulations and guidance, looks at newer research, and defines "peptide" and "peptide-based therapy" for the purposes of the act. 2️⃣ STUDY (18 months) The VA studies the safety, efficacy, and potential benefits of peptide-based therapies for veterans. That includes reviewing the research and setting clinical protocols. Areas of interest include recovery, rehabilitation, chronic pain, mental health, and physical wellness. Then it sends a report with recommendations to Congress. 3️⃣ PILOT (only if the evidence supports it) If the VA concludes peptide therapies should be offered, it would run a voluntary pilot that could be limited by geography or clinical criteria. It would run up to 5 years, followed by a final report on results and challenges. ━━━━━━━━━━━━━━━━━━━━ 🚫 WHAT THE BILL DOES NOT DO • Does not make peptides available through the VA right now • Does not require VA doctors to prescribe them • Does not override FDA authority • Does not declare any specific peptide safe or effective • Does not approve BPC-157, TB-500, Semax, MOTS-c, KPV, Epitalon, or any other named compound • Does not legalize sale, import, compounding, or human use of unapproved peptides It is a "study it first" bill, not an "access for everyone" bill. ━━━━━━━━━━━━━━━━━━━━

Yesterday I asked: When you look at a peptide COA, what’s the first thing you check? Now let’s break down some of the important things a Certificate of Analysis can tell you — and what it doesn’t tell you. 1. Identity First question: Is the compound actually what the label says it is? Depending on the testing method, identity may be evaluated using techniques such as mass spectrometry. A purity percentage alone does not necessarily establish identity. 2. Purity HPLC (High-Performance Liquid Chromatography) is commonly used to evaluate peptide purity. You may see results such as 98%, 99%, or 99%+ purity. Remember: purity describes the proportion of detected material represented by the target compound under that analytical method. It does not automatically tell you how many milligrams are in the vial. 3. Quantity / Peptide Content This is different from purity. A vial can test at very high purity and still contain more or less peptide than the amount stated on the label. Look for testing that actually evaluates peptide content or quantity, when available. 4. Sterility & Endotoxin Testing These are separate tests from purity and identity. A standard HPLC purity report does not prove that a sample is sterile or establish its endotoxin level. If those characteristics are being claimed, look for the appropriate separate testing. 5. Lot or Batch Number The COA should be traceable to the specific batch or lot it represents. A beautiful COA isn't very useful if you can't determine whether it corresponds to the actual batch being discussed. 6. Testing Date Check when the sample was analyzed. Testing dates help establish when the reported results were obtained. 7. Testing Laboratory Look at who performed the analysis. Ideally, the laboratory and report should be independently verifiable rather than relying solely on a screenshot supplied by a seller. THE BIG TAKEAWAY Purity ≠ quantity ≠ sterility ≠ identity. They answer different questions and may require different analytical methods.